Retroviruses and psoriasis

Area of Science:

• Immunology
• Dermatology
• Virology

Background:

• Psoriasis occurs frequently in individuals with Human Immunodeficiency Virus (HIV) infection.
• HIV-induced profound immunodysregulation impacts psoriasis pathogenesis and treatment.
• The paradoxical exacerbation of psoriasis by HIV, despite T-lymphocyte-targeting therapies' efficacy, warrants investigation.

Purpose of the Study:

• To explore the pathogenesis and therapeutic strategies for psoriasis in the context of HIV infection.
• To investigate the immunological basis of psoriasis, particularly the roles of CD4+ and CD8+ T lymphocytes.
• To understand how HIV-associated immunodysregulation may trigger psoriasis in genetically susceptible individuals.

Main Methods:

• Review of existing literature on psoriasis and HIV co-infection.
• Analysis of immunological data, including T-lymphocyte roles and Human Leukocyte Antigen (HLA) associations.
• Consideration of the impact of antiretroviral therapy on psoriasis presentation.

Main Results:

• HIV infection does not diminish the frequency of psoriasis.
• Antiretroviral therapy can lead to psoriasis improvement.
• A Human Leukocyte Antigen class I association, specifically HLA-Cw*0602, is identified in HIV-associated psoriasis, suggesting a role for CD8+ T lymphocytes.

Conclusions:

• HIV-associated immunodysregulation may trigger psoriasis in genetically predisposed individuals (e.g., carrying HLA-Cw*0602).
• CD8+ T lymphocytes likely play a significant role in the immunopathogenesis of HIV-associated psoriasis.
• Human retrovirus-5 is not implicated in the pathogenesis of psoriasis itself.